Amiloride, a diuretic drug that acts by inhibition of various sodium transporters, is toxic to the fission yeast Schizosaccharomyces pombe. Previous work has established that amiloride sensitivity is caused by expression of car1 ؉ , which encodes a protein with similarity to plasma membrane drug/proton antiporters from the multidrug resistance family. Here we isolated car1؉ by complementation of Saccharomyces cerevisiae mutants that are deficient in pyridoxine biosynthesis and uptake. Our data show that Car1p represents a new high-affinity, plasma membrane-localized import carrier for pyridoxine, pyridoxal, and pyridoxamine. We therefore propose the gene name bsu1 ؉ (for vitamin B 6 uptake) to replace car1 ؉ . Bsu1p displays an acidic pH optimum and is inhibited by various protonophores, demonstrating that the protein works as a proton symporter. The expression of bsu1 ؉ is associated with amiloride sensitivity and pyridoxine uptake in both S. cerevisiae and S. pombe cells. Moreover, amiloride acts as a competitor of pyridoxine uptake, demonstrating that both compounds are substrates of Bsu1p. Taken together, our data show that S. pombe and S. cerevisiae possess unrelated plasma membrane pyridoxine transporters. The S. pombe protein may be structurally related to the unknown human pyridoxine transporter, which is also inhibited by amiloride.Vitamin B 6 is a generic term describing a group of three water-soluble vitamins, pyridoxine (PN), pyridoxal (PL), and pyridoxamine (PM), and the 5Ј-phosphates derived therefrom. Vitamin B 6 is synthesized in plants and most microorganisms but cannot be produced by mammals and thus represents an essential component of the human diet.Vitamin B 6 has a central role in the metabolism of amino acids. PL phosphate (PLP) is the cofactor of amino acid transaminases and decarboxylases and enzymes involved in elimination and replacement reactions (19). A more recently discovered function of vitamin B 6 is protection from reactive oxygen species: PN and PLP are as effective as the well-established antioxidant vitamins C and E in quenching singlet oxygen species (6, 10). Moreover, vitamin B 6 is an intermediate in the synthesis of thiamine (vitamin B 1 ). This metabolic pathway is best known for S. cerevisiae cells, where the pyrimidine moiety of thiamine derives from histidine and PN (reference 49 and references therein). The S. cerevisiae THI5 and THI20 gene families are involved in this pathway (44), and both families have orthologues in many other yeast species. Thus, the yeast thiamine biosynthetic pathway is different from the pathway found in many prokaryotes, where PN is not used as a precursor (43). In addition to having evolved different strategies to synthesize the pyrimidine unit of thiamine, synthesis of the thiazole moiety also follows different routes in pro-and eukaryotes (43).To date, two different pathways for PN biosynthesis have been described. The two pathways differ in the origin of the ring nitrogen of PN that is derived from the amide group of glutamine in S. cer...